We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$1.65B
AUM Growth
+$152M
Cap. Flow
+$78.5M
Cap. Flow %
4.74%
Top 10 Hldgs %
30.2%
Holding
122
New
5
Increased
60
Reduced
31
Closed
9

Top Buys

Rank Stock Value
1
DSGX icon
Descartes Systems
DSGX
+$16.6M
2
WDFC icon
WD-40
WDFC
+$14.4M
3
JBTM
JBT Marel
JBTM
+$9.67M
4
LMAT icon
LeMaitre Vascular
LMAT
+$9.1M
5
TECH icon
Bio-Techne
TECH
+$8.73M

Sector Composition

Rank Sector Weight
1 Healthcare 25.02%
2 Industrials 23.76%
3 Technology 21.88%
4 Consumer Discretionary 7.35%
5 Materials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAY
26
DELISTED
Bottomline Technologies Inc
EPAY
$34.2M 2.07%
1,446,869
+70,375
+5% +$1.77M
PRO
27
DELISTED
PROS Holdings
PRO
$34.1M 2.06%
1,408,121
+37,820
+3% +$854K
TREX icon
28
Trex
TREX
$4.51B
$33.9M 2.05%
1,951,704
+101,492
+5% +$1.75M
EGOV
29
DELISTED
NIC Inc
EGOV
$33.1M 2%
1,640,018
+75,228
+5% +$1.69M
TYL icon
30
Tyler Technologies
TYL
$12.7B
$33M 1.99%
213,308
+4,115
+2% +$626K
BID
31
DELISTED
Sotheby's
BID
$30.7M 1.86%
675,193
+50,488
+8% +$2.16M
HLIO icon
32
Helios Technologies
HLIO
$2.57B
$29M 1.75%
803,976
-14,107
-2% -$529K
WHG icon
33
Westwood Holdings Group
WHG
$182M
$28.1M 1.7%
525,426
+13,735
+3% +$785K
BCPC
34
Balchem Corp
BCPC
$5.38B
$26.7M 1.61%
324,099
+30,811
+11% +$2.59M
MTDR icon
35
Matador Resources
MTDR
$6.2B
$26.7M 1.61%
1,120,330
-17,960
-2% -$449K
TECH icon
36
Bio-Techne
TECH
$11.2B
$26M 1.57%
1,024,852
+338,276
+49% +$8.73M
ROG icon
37
Rogers Corp
ROG
$2.21B
$23.4M 1.41%
272,383
+8,833
+3% +$722K
CSGP icon
38
CoStar Group
CSGP
$11.7B
$23.1M 1.4%
1,114,700
+45,640
+4% +$927K
PRLB icon
39
Protolabs
PRLB
$1.79B
$21.5M 1.3%
420,533
+22,502
+6% +$1.19M
JBTM
40
JBT Marel
JBTM
$7.21B
$21.2M 1.28%
240,846
+111,586
+86% +$9.67M
MINI
41
DELISTED
Mobile Mini Inc
MINI
$21.1M 1.28%
692,955
+42,874
+7% +$1.34M
NVEC icon
42
NVE Corp
NVEC
$562M
$19.7M 1.19%
238,377
-46,425
-16% -$3.6M
EXA
43
DELISTED
EXA Corporation
EXA
$19.5M 1.18%
1,536,055
-20,510
-1% -$314K
WDFC icon
44
WD-40
WDFC
$3.05B
$16.9M 1.02%
155,185
+132,035
+570% +$14.4M
LMAT icon
45
LeMaitre Vascular
LMAT
$2.32B
$9.55M 0.58%
+387,690
New +$9.1M
ESE icon
46
ESCO Technologies
ESE
$8.17B
$8.65M 0.52%
+148,894
New +$8.36M
NRCIB
47
DELISTED
National Research Corp Class B
NRCIB
$8.04M 0.49%
204,724
-1,049
-0.5% -$42.2K
NRC icon
48
NRC Health Common Stock
NRC
$432M
$7.89M 0.48%
400,620
-5,635
-1% -$104K
ANSS
49
DELISTED
Ansys
ANSS
$2.75M 0.17%
25,709
+12,600
+96% +$1.26M
CPRT icon
50
Copart
CPRT
$27B
$2.37M 0.14%
306,688
+172,800
+129% +$1.27M

Similar funds

Conestoga Capital Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Conestoga Capital Advisors held 122 positions worth $1.65B, up 10% from $1.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Conestoga Capital Advisors deployed $78.5M of net new capital in Q1 2017, opening 5 new positions and adding to 60 existing holdings. Its largest new stake was LeMaitre Vascular: 387,690 shares worth $9.55M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was NVE Corp, an estimated $3.6M trimmed.

  • Conestoga Capital Advisors's largest Q1 2017 buy was LeMaitre Vascular: 387,690 shares worth $9.55M.
  • Conestoga Capital Advisors added most to Descartes Systems in Q1 2017, an estimated $16.6M increase.
  • Conestoga Capital Advisors's biggest Q1 2017 reduction was NVE Corp, cutting an estimated $3.6M.
  • Conestoga Capital Advisors fully exited Vascular Solutions Inc in Q1 2017, selling an estimated $43.7M.
  • Conestoga Capital Advisors's ten largest holdings make up 30% of its $1.65B portfolio in Q1 2017.
  • Conestoga Capital Advisors opened 5 new positions and closed 9 in Q1 2017.
  • Conestoga Capital Advisors's portfolio value rose 10% quarter-over-quarter to $1.65B.

Based on Conestoga Capital Advisors's 13F filing for Q1 2017, filed 19 Apr 2017.